CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
MOESM2 of Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
Authors
Aharon Erez (3569525)
Alexander Tenenbaum (326246)
+6 more
Enrique Fisman (3431555)
Ilan Goldenberg (326261)
Nir Shlomo (686408)
Robert Klempfner (326258)
Sagit Benzekry (3569528)
Yaron Arbel (3569531)
Publication date
Publisher
Doi
Cite
Abstract
Additional file 2: Table B. Baseline Clinical and Laboratory Characteristics of the study cohort by triglyceride level ⼠and < 200 mg/dl
Similar works
Full text
Available Versions
FigShare
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:figshare.com:article/44588...
Last time updated on 12/02/2018
FigShare
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:figshare.com:article/44587...
Last time updated on 12/02/2018
